RION
RION is a clinical-stage regenerative medicine company based in Rochester, MN, focused on revolutionizing exosome science to heal from within. Established in 2017, RION leverages the unique properties of exosomes derived from platelets to develop innovative therapies aimed at enhancing tissue regeneration and addressing various medical challenges.
What We Do
A novel ingredient developed by RION, PEP™ is a lyophilized powder containing up to 2 trillion regenerative exosomes per vial, designed to promote tissue regeneration across various applications.
Application Area
Key People
Co-Founder
Co-Founder
Chief Financial Officer
Chief Regulatory Officer
Chief Administrative Officer
Chief Technical Operations
News & Updates
RION received recognition for its innovative contributions to the field of regenerative medicine.
RION has strengthened its leadership team by appointing five experts to its advisory boards.
RION has begun a clinical study to assess the effectiveness of PEP™ in treating knee osteoarthritis.
The company has successfully dosed its first patient in a clinical study targeting diabetic foot ulcers with PEP™.
RION has announced the expansion of its manufacturing capabilities with a new facility in Rochester.